EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase III)

Structured Fresh Apple Consumption for Birch Pollen Food Allergy Syndrome in an Uncontrolled Phase II/III Trial

Bettina Mueller, Norbert Reider, Hilal Demir, Barbara Bohle, Laurent Marquer, Aylin Yildirim, Jenny Deluca, Valentina Cova, Linda Ahammer, Reiner Eidelpes, Jana Unterhauser, Martin Tollinger und 2 weitere

The Journal of Allergy and Clinical Immunology: In Practice · 2025

DOI: 10.1016/j.jaip.2025.06.030 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025. Verfasst von Bettina Mueller und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Malus, Food Hypersensitivity, Betula, Desensitization, Immunologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: European Regional Development Fund, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Birch pollen food allergy syndrome to apples is prevalent, but no approved or standardized treatment exists so far. OBJECTIVE: To investigate the effect of oral therapy with fresh apples on birch pollen food allergy syndrome to apples using a feasible treatment protocol with different widely available apple cultivars. METHODS: In this uncontrolled phase II/III study, 42 apple cultivars were tested for their allergen content in vivo by skin prick tests and oral provocations. Afterward, 36 patients consumed apples of increasing dose and allergenicity over a period of 12 months. Side effects were documented weekly in a clinical diary. Efficacy was tested before and after therapy by oral provocation and a skin prick test with the Golden Delicious apple. Total IgE, specific IgE, and IgG4 for Mal d 1 and inhibition of basophil activation were analyzed before and after treatment. Other cross-reactive foods were determined by a questionnaire before and after therapy. RESULTS: Oral immunotherapy with apples resulted in a consistent and durable tolerance of apples and a significant augmented tolerance to other Bet v 1 cross-reactive foods. After therapy, specific IgG4 antibodies to Mal d 1 increased significantly; simultaneously specific IgE to Mal d 1 and skin prick test reactivity to apples decreased significantly. Moreover, sera of treated patients displayed blocking activity to Mal d 1. CONCLUSION: Oral allergy-specific immunotherapy with fresh apples is a promising treatment for birch pollen food allergy syndrome to apples and other Bet v 1 cross-reactive foods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MalusFood HypersensitivityBetulaDesensitization, ImmunologicRhinitis, Allergic, SeasonalHumansFemaleMaleAdultImmunoglobulin EAllergensMiddle AgedPollenAntigens, PlantImmunoglobulin GSkin TestsYoung AdultPlant ProteinsCross ReactionsAdolescentBasophilsOral Allergy Syndrome

Stichwörter der Autor:innen

AppleBet v 1Birch pollen allergyBirch pollen food allergy syndromeImmunotherapyMal d 1

Substanzen

Immunoglobulin EAllergensAntigens, PlantImmunoglobulin GMALD1 protein, Malus domesticaPlant Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Institute of Botany, University of Innsbruck, Innsbruck, Austria.
  • Department of Dermatology, Venereology and Allergology, Central Teaching Hospital, Bolzano/Bozen, Italy.
  • Department of Applied Genomics and Molecular Biology, Laimburg Research Centre, Ora, Italy.
  • Institute of Organic Chemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.

Förderung

  • European Regional Development Fund
  • Austrian Science Fund

Zitieren

APA

Mueller, B., Reider, N., Demir, H., Bohle, B., Marquer, L., Yildirim, A., Deluca, J., Cova, V., Ahammer, L., Eidelpes, R., Unterhauser, J., Tollinger, M., Letschka, T., & Eisendle, K. (2025). Structured Fresh Apple Consumption for Birch Pollen Food Allergy Syndrome in an Uncontrolled Phase II/III Trial. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.06.030

Vancouver

Mueller B, Reider N, Demir H, Bohle B, Marquer L, Yildirim A, et al. Structured Fresh Apple Consumption for Birch Pollen Food Allergy Syndrome in an Uncontrolled Phase II/III Trial. The Journal of Allergy and Clinical Immunology: In Practice. 2025. doi:10.1016/j.jaip.2025.06.030

BibTeX
@article{Mueller2025,
  author = {Mueller, Bettina and Reider, Norbert and Demir, Hilal and Bohle, Barbara and Marquer, Laurent and Yildirim, Aylin and Deluca, Jenny and Cova, Valentina and Ahammer, Linda and Eidelpes, Reiner and Unterhauser, Jana and Tollinger, Martin and Letschka, Thomas and Eisendle, Klaus},
  title = {Structured Fresh Apple Consumption for Birch Pollen Food Allergy Syndrome in an Uncontrolled Phase II/III Trial},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2025},
  doi = {10.1016/j.jaip.2025.06.030}
}
Kostenlos starten →